United Capital Management Of Ks, Inc. Context Therapeutics Inc. Transaction History
United Capital Management Of Ks, Inc.
- $476 Million
- Q4 2024
A detailed history of United Capital Management Of Ks, Inc. transactions in Context Therapeutics Inc. stock. As of the latest transaction made, United Capital Management Of Ks, Inc. holds 10,000 shares of CNTX stock, worth $8,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$8,500% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNTX
# of Institutions
55Shares Held
72.9MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$12.5 Million2.18% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$6.36 Million0.84% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$6.31 Million0.32% of portfolio
-
Nextech Invest Ag7.42MShares$6.31 Million1.37% of portfolio
-
Blue Owl Capital Holdings LP New York, NY6.36MShares$5.4 Million2.69% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $13.6M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...